Form 8-K - Current report:
SEC Accession No. 0001104659-24-130537
Filing Date
2024-12-20
Accepted
2024-12-20 09:21:09
Documents
16
Period of Report
2024-12-16
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2431397d1_8k.htm   iXBRL 8-K 32230
2 EXHIBIT 10.1 tm2431397d1_ex10-1.htm EX-10.1 7697
3 EXHIBIT 10.2 tm2431397d1_ex10-2.htm EX-10.2 40492
4 EXHIBIT 99.1 tm2431397d1_ex99-1.htm EX-99.1 8315
  Complete submission text file 0001104659-24-130537.txt   282390

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA snpx-20241216.xsd EX-101.SCH 3021
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE snpx-20241216_lab.xml EX-101.LAB 34240
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE snpx-20241216_pre.xml EX-101.PRE 22363
18 EXTRACTED XBRL INSTANCE DOCUMENT tm2431397d1_8k_htm.xml XML 3802
Mailing Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036
Business Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036 9732420005
Synaptogenix, Inc. (Filer) CIK: 0001571934 (see all company filings)

EIN.: 461585656 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40458 | Film No.: 241565376
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)